Summary
Updated Aug 30, 2026
Thomas Sciascia is Chief Scientific Officer of Trevi Therapeutics, Inc. (TRVI). 2 SEC Form 4 filings on record going back to 2025, most recently on 20 February 2026.
Trading Pattern
InsiderAlpha's records for Thomas Sciascia go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Thomas Sciascia's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BROADWOOD PARTNERS, L.P. - $62.75M of STAA open-market activity in the last 12 months
- Jonathan M. Rothberg - $62.19M of BFLY open-market activity in the last 12 months
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Vivek Ramaswamy - $60.40M of ROIV open-market activity in the last 12 months
- David Cordani - $60.11M of CI open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Thomas Sciascia?
Thomas Sciascia is a corporate insider, tracked as Chief Scientific Officer of Trevi Therapeutics, Inc. (TRVI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas Sciascia last file a Form 4?
The most recent primary Form 4 on record is dated 20 February 2026, one of 2 filings going back to 2025.
Where can I see all of Thomas Sciascia's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Thomas Sciascia and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial